Clinical and Angiographic Outcomes of Post-drug-coated Balloon Angioplasty in Native Coronary Lesions

RecruitingOBSERVATIONAL
Enrollment

303

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2025

Conditions
Coronary Artery Disease
Interventions
DEVICE

DCB Angioplasty

Drug-coated balloons (DCB) are designed to deliver drugs (antiproliferative drugs: Paclitaxel, Sirolimus etc.) to the target lesion/vessel wall without leaving nothing behind unlike stent strut or drug delivery system. Drug coated balloons (DCB) allow the homogenous transfer of an anti-proliferative drug to reduce neo-intimal hyperplasia whilst maintaining normal vessel anatomy and function

Trial Locations (1)

1207

RECRUITING

National Institute of CardioVascular Diseases, Dhaka

All Listed Sponsors
lead

National Institute of Cardiovascular Diseases, Bangladesh

OTHER